Contribution of the addition of anti-ββ2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome

被引:5
作者
Oron, Galia [4 ]
Ben-Haroush, Avi [1 ,4 ]
Goldfarb, Rachel [4 ]
Molad, Yair [2 ,4 ]
Hod, Moshe [4 ]
Bar, Jacob [3 ,4 ]
机构
[1] Helen Schneider Hosp Women, Rabin Med Ctr, Perinatal Div, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Rheumatol Unit, Lupus Clin, Petah Tiqwa, Israel
[3] Wolfson Med Ctr, Perinatal Div, Holon, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
Anti-beta; 2; glycoprotein; 1; antiphospholipid syndrome; pregnancy; complications; INTERNATIONAL CONSENSUS STATEMENT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; EUROPEAN-FORUM; ANTIBODIES; CRITERIA; RISK; ANTI-BETA(2)-GLYCOPROTEIN-I; AUTOANTIBODIES; ASSOCIATION; UPDATE;
D O I
10.3109/14767058.2010.511339
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Methods. aEuro integral A retrospective cohort design was used. Ninety-one patients (total 394 pregnancies) referred to a tertiary medical center for evaluation of clinical features consistent with APS were divided into three groups: group A (n == 34), two positive tests for anticardiolipin (ACL) or lupus anticoagulant (LAC), in accordance with original APS classification (1998); group B (n == 18), two positive tests for a-beta beta 2GP1, in accordance with the revised APS criteria; and group C (n == 39), only one positive test for ACL or LAC. Results. aEuro integral Of the 52 women with APS (group A or B), 36 had primary disease, and 16 had secondary disease. On comparison of the groups, group B was characterized by a significantly higher rate of complicated pregnancy (83.3%%) than groups A (47.1%%) and C (76.9%%), P == 0.007, and a higher rate of fetal loss (72.2%%) than groups A ++ C (28.8%%, P == 0.001). Conclusions. aEuro integral The findings suggest that the revised APS criteria are preferable to the original classification for the prediction of complicated pregnancy.
引用
收藏
页码:606 / 609
页数:4
相关论文
共 50 条
  • [41] Anti-β2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant
    Sailer, Thomas
    Zoghlami, Claudia
    Kurz, Christine
    Rumpold, Helmut
    Quehenberger, Peter
    Panzer, Simon
    Pabinger, Ingrid
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (05) : 796 - 801
  • [42] Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
    Banos, Nuria
    Castellanos, Aleida
    Barilaro, Giuseppe
    Figueras, Francesc
    Lledo, Gema
    Santana, Marta
    Espinosa, Gerard
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)
  • [43] Serum anti-β2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells
    Caronti, B
    Calderaro, C
    Alessandri, C
    Conti, F
    Tinghino, R
    Pini, C
    Palladini, G
    Valesini, G
    JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) : 425 - 429
  • [44] Prevalence of anticardiolipin and anti-β2-glycoprotein I antibodies in celiac disease
    Karoui, Sami
    Sellami, Maryam Kallel
    Laatar, Asma Belkhodja
    Zitouni, Mondher
    Matri, Samira
    Laadhar, Lilia
    Fekih, Monia
    Boubaker, Jalel
    Makni, Sondes
    Filali, Azza
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (04) : 1096 - 1100
  • [45] The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
    Chayoua, Walid
    Kelchtermans, Hilde
    Gris, Jean-Christophe
    Moore, Gary W.
    Musial, Jacek
    Wahl, Denis
    de Groot, Philip G.
    de Laat, Bas
    Devreese, Katrien M. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (01) : 169 - 179
  • [46] Binding of high-avidity anti-β2-glycoprotein I antibodies
    Cucnik, S
    Kveder, T
    Rozman, B
    Bozic, B
    RHEUMATOLOGY, 2004, 43 (11) : 1353 - 1356
  • [47] Prevalence of Anticardiolipin and Anti-β2-Glycoprotein I Antibodies in Celiac Disease
    Sami Karoui
    Maryam Kallel Sellami
    Asma Belkhodja Laatar
    Mondher Zitouni
    Samira Matri
    Lilia Laadhar
    Monia Fekih
    Jalel Boubaker
    Sondes Makni
    Azza Filali
    Digestive Diseases and Sciences, 2007, 52 : 1096 - 1100
  • [48] First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2-Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests
    Nakamura, Hiroyuki
    Oku, Kenji
    Amengual, Olga
    Ohmura, Kazumasa
    Fujieda, Yuichiro
    Kato, Masaru
    Bohgaki, Toshiyuki
    Yasuda, Shinsuke
    Atsumi, Tatsuya
    ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 627 - 634
  • [49] Anti-beta 2-glycoprotein I antibodies: A useful marker for the antiphospholipid syndrome
    Teixido, M
    Font, J
    Reverter, JC
    Cervera, R
    Tassies, D
    Ingelmo, M
    Escolar, G
    Ordinas, A
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (01): : 113 - 116
  • [50] Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
    Ruiz-Garcia, Raquel
    Serrano, Manuel
    Angel Martinez-Flores, Jose
    Mora, Sergio
    Morillas, Luis
    Angeles Martin-Mola, Maria
    Morales, Jose M.
    Paz-Artal, Estela
    Serrano, Antonio
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014